功能化氨酸生物材料通过CD44介导向和细胞表面工程来促进癌症免疫疗法:一篇综述
Ashok Kumar Jangid1, Kyung Mu Noh1, Chae Eun Lee1
1Department of Chemical & Biochemical Engineering, Dongguk University, Seoul, 04620, Republic of Korea.
International journal of biological macromolecules
|September 9, 2025
概括
改性氨酸 (HA) 生物材料提供了创新的癌症免疫治疗策略. 这些基于HA的材料增强药物输送,促进细胞相互作用,并通过CD44向触发抗瘤免疫力.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 药物运输 药物运输 药物运输
背景情况:
- 氨酸 (HA) 是一种多功能生物聚合物,在治疗应用中具有显著的潜力.
- 改性HA生物材料越来越多地被用于针对性疾病干预,药物输送和癌症免疫治疗.
- HA的独特特性促进了治疗屏蔽,安全的分娩和细胞吸收.
研究的目的:
- 审查用于治疗应用的改性氨酸 (HA) 生物材料的进展.
- 检查HA在促进免疫反应中的作用及其在癌症免疫治疗中的应用.
- 探索脂质修饰的HA用于细胞表面工程和CD44介导向.
主要方法:
- 对基于HA的生物材料的最新文献的综述.
- 对HA与CD44的相互作用进行细胞向和免疫调节的分析.
- 基于HA的各种生物材料的分类 (例如,HA药物联合体,HA脂质).
主要成果:
- 改性HA生物材料可以增强药物输送和癌症免疫治疗.
- HA-CD44的相互作用改善了细胞与细胞的结合和抗瘤反应.
- 各种基于HA的材料,如HA-药物联物,HA-脂质,HA-和HA-脂质体调节免疫反应.
结论:
- 基于HA的生物材料对局部瘤治疗和促进抗瘤免疫力有希望.
- 使用修改HA的CD44介导向提供了一种增强细胞与细胞相互作用的策略.
- 未来的研究方向重点是推进基于HA的癌症免疫疗法.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K


